Sara Bruno, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 756 Route 1, Yarmouth, ME 04096 Phone: 207-846-5251 |
William John Estrella, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 756 Us Route 1, Yarmouth, ME 04096 Phone: 207-846-5251 |
Alana Cobb, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 756 Route 1 Stop 4, Yarmouth, ME 04096 Phone: 207-846-4251 |
Mr. Jamie Charron Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 478 Route 1, Yarmouth, ME 04096 Phone: 207-846-1222 |
Andrea Donovan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 756 Us Route 1 Stop 4, Yarmouth, ME 04096 Phone: 207-846-5251 Fax: 207-846-2233 |
Dr. Derek Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Forest Falls Dr, Suite 4, Yarmouth, ME 04096 Phone: 207-846-1375 |
Joanna L Thomas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 478 Us-1, Yarmouth, ME 04096 Phone: 207-846-1222 |
Laura Gall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 756 Us Route 1, Hannaford Pharmacy, Yarmouth, ME 04096 Phone: 207-846-5251 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
Three in four women starting fertility treatment will have a baby within five years, whether as a result of the treatment or following natural conception.
As part of World Health Day 2011, the World Health Organization is calling on policy makers, providers, the public and the healthcare industry to take action to combat the serious health threat of antimicrobial resistance.
Scientists at Biocontrol, leading the world in developing new treatments to cure serious antibiotic-resistant infections, have secured a £250,000 investment from The Capital Fund.
The New Jersey Hospital Association and Applied Medical Software have received the "Innovation Award" from the American College of Healthcare Executives New Jersey for their pioneering initiative to improve healthcare value and reduce costs by promoting better coordination and collaboration among New Jersey hospitals and physicians.
› Verified 6 days ago